| 651 | CLDXCelldex Therapeutics, Inc. |
US$ 1,5 mi |
-16.748,0% |
2025 |
| 652 | ATPCAgape ATP Corp |
US$ 1,5 mi |
-149,6% |
2025 |
| 653 | DXRDaxor Corp |
US$ 1,4 mi |
-496,8% |
2011 |
| 654 | NRXPNRX Pharmaceuticals, Inc. |
US$ 1,4 mi |
-1.980,8% |
2025 |
| 655 | OTLKOutlook Therapeutics, Inc. |
US$ 1,4 mi |
-4.416,2% |
2025 |
| 656 | ATXIAvenue Therapeutics, Inc. |
US$ 1,4 mi |
-207,2% |
2025 |
| 657 | NWBONorthwest Biotherapeutics Inc |
US$ 1,4 mi |
-4.365,9% |
2025 |
| 658 | CPMDCannapharmarx, Inc. |
US$ 1,4 mi |
-817,2% |
2025 |
| 659 | ONMDOneMedNet Corp |
US$ 1,4 mi |
-206,1% |
2025 |
| 660 | EMEDElectromedical Technologies, Inc |
US$ 1,3 mi |
-195,8% |
2023 |
| 661 | SCNIScinai Immunotherapeutics Ltd. |
US$ 1,3 mi |
-633,6% |
2025 |
| 662 | SPRCSciSparc Ltd. |
US$ 1,3 mi |
-481,2% |
2024 |
| 663 | INBXInhibrx Biosciences, Inc. |
US$ 1,3 mi |
-10.773,5% |
2025 |
| 664 | IGCIGC Pharma, Inc. |
US$ 1,3 mi |
-560,3% |
2025 |
| 665 | VTGNVistagen Therapeutics, Inc. |
US$ 1,3 mi |
-5.491,3% |
2026 |
| 666 | ICUSeaStar Medical Holding Corp |
US$ 1,2 mi |
-984,6% |
2025 |
| 667 | LGVNLongeveron Inc. |
US$ 1,2 mi |
-1.893,6% |
2025 |
| 668 | BLRXBioLineRx Ltd. |
US$ 1,2 mi |
-171,7% |
2025 |
| 669 | NEUPNeuphoria Therapeutics Inc. |
US$ 1,2 mi |
-1.145,7% |
2026 |
| 670 | PETVPetVivo Holdings, Inc. |
US$ 1,1 mi |
-917,4% |
2026 |
| 671 | SXTCChina SXT Pharmaceuticals, Inc. |
US$ 1,1 mi |
-545,2% |
2026 |
| 672 | RNXTRenovoRx, Inc. |
US$ 1,1 mi |
-994,5% |
2025 |
| 673 | BSPKBespoke Extracts, Inc. |
US$ 1,1 mi |
-92,8% |
2024 |
| 674 | DAREDare Bioscience, Inc. |
US$ 1 mi |
-1.300,7% |
2025 |
| 675 | EHSIElite Health Systems Inc. |
US$ 1 mi |
-762,1% |
2025 |
| 676 | SINTSintx Technologies, Inc. |
US$ 1 mi |
-1.018,1% |
2025 |
| 677 | PLURPluri Inc. |
US$ 1 mi |
-2.344,6% |
2026 |
| 678 | SXTP60 Degrees Pharmaceuticals, Inc. |
US$ 1 mi |
-732,5% |
2025 |
| 679 | STTKShattuck Labs, Inc. |
US$ 1 mi |
-4.880,9% |
2025 |
| 680 | RFLRafael Holdings, Inc. |
US$ 917 mil |
-3.328,2% |
2025 |
| 681 | PROKProkidney Corp. |
US$ 893 mil |
-7.725,2% |
2025 |
| 682 | HWHHWH International Inc. |
US$ 866,9 mil |
-303,4% |
2025 |
| 683 | RLYBRallybio Corp |
US$ 858 mil |
-1.046,4% |
2025 |
| 684 | AKANAkanda Corp. |
US$ 836,7 mil |
-489,6% |
2024 |
| 685 | VTAKCatheter Precision, Inc. |
US$ 819 mil |
-2.098,0% |
2025 |
| 686 | ONCOOnconetix, Inc. |
US$ 815,4 mil |
-1.721,0% |
2025 |
| 687 | HYPDHyperion Defi, Inc. |
US$ 813,5 mil |
-5.570,6% |
2025 |
| 688 | IMAImageneBio, Inc. |
US$ 800 mil |
-5.668,6% |
2025 |
| 689 | BICXBioCorRx Inc. |
US$ 797,2 mil |
-431,5% |
2025 |
| 690 | MCRBSeres Therapeutics, Inc. |
US$ 789 mil |
721,9% |
2025 |
| 691 | GTHPGuided Therapeutics Inc |
US$ 767 mil |
-416,7% |
2025 |
| 692 | BGMSBio Green Med Solution, Inc. |
US$ 747 mil |
-401,3% |
2025 |
| 693 | LEXXLexaria Bioscience Corp. |
US$ 705,9 mil |
-1.686,0% |
2025 |
| 694 | HRGNHarvard Apparatus Regenerative Technology, Inc. |
US$ 704 mil |
-975,7% |
2025 |
| 695 | ADIAAdia Nutrition, Inc. |
US$ 700,5 mil |
-56,5% |
2025 |
| 696 | PMHSPolomar Health Services, Inc. |
US$ 648,2 mil |
-1.650,8% |
2025 |
| 697 | BTAIBioXcel Therapeutics, Inc. |
US$ 642 mil |
-10.887,4% |
2025 |
| 698 | CODXCo-Diagnostics, Inc. |
US$ 622,5 mil |
-7.533,6% |
2025 |
| 699 | SPAISafe Pro Group Inc. |
US$ 606,7 mil |
-2.360,8% |
2025 |
| 700 | VCNXVaccinex, Inc. |
US$ 601 mil |
-3.100,5% |
2024 |